Stockscreener 앱 받기
21.29
0.88%
-0.19
시간 외 거래:
21.29
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023TNDM - ACCESS Newswire
Earnings Release: Here's Why Analysts Cut Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$35.52 - simplywall.st
Tandem Diabetes jumps as overseas sales drive Q1 beat - MSN
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Tandem Diabetes Care, Inc.(TNDM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2025 Earnings Call Transcript - Insider Monkey
TNDM Stock Rises Despite Q1 Earnings Miss, Gross Margin Up - Yahoo Finance
Tandem Diabetes Care First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Tandem Diabetes Care (TNDM): Analyst Maintains "Buy" Rating and Raises Target Price | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Shares Surge on Robust Q1 Revenue - GuruFocus
Tandem Diabetes Care Reports Record Sales and Strategic Growth - TipRanks
Tandem Diabetes stock jumps on Q1 results (TNDM:NASDAQ) - Seeking Alpha
TNDM: Stifel Adjusts Price Target for Tandem Diabetes Care | TND - GuruFocus
Tandem Diabetes Care (TNDM) Target Price Lowered by Wells Fargo - GuruFocus
TNDM: Piper Sandler Adjusts Price Target Amid Overweight Rating - GuruFocus
TNDM: Piper Sandler Adjusts Price Target Amid Overweight Rating | TNDM Stock News - GuruFocus
TNDM: Baird Maintains Neutral Rating, Lowers Price Target | TNDM Stock News - GuruFocus
Canaccord raises Tandem Diabetes Care target to $59 - Investing.com
Tandem Diabetes Care Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) - Benzinga
Tandem Diabetes (TNDM) Sees Price Target Reduced by Baird | TNDM Stock News - GuruFocus
Tandem Diabetes (TNDM) Price Target Raised by Canaccord Amid Pro - GuruFocus
Tandem Diabetes (TNDM) Target Price Revised as Analysts Remain O - GuruFocus
Tandem Diabetes (TNDM) Price Target Adjusted by Analyst | TNDM S - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings: Revenue Surpas - GuruFocus
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo
Tandem Diabetes Care Reports 22.3% Revenue Increase in Q1 CY2025News and Statistics - IndexBox
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights - GuruFocus
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Nasdaq
Tandem Diabetes Care Announces First Quarter 2025 Financial Results - BioSpace
Earnings call transcript: Tandem Diabetes Care Q1 2025 Misses EPS, Stock Rises - Investing.com
Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars - Barchart.com
Tandem Diabetes Q1 2025 slides: dual-platform strategy targets underpenetrated market - Investing.com
Tandem Diabetes stock surges on revenue beat, strong guidance By Investing.com - Investing.com South Africa
Tandem Diabetes stock surges on revenue beat, strong guidance - Investing.com Australia
Tandem Diabetes Care Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Tandem's (TNDM) Strong Q1 Revenue Surpasses Expectations | TNDM Stock News - GuruFocus
Earnings Flash (TNDM) Tandem Diabetes Care Reports Q1 Loss $-1.97 Per Share, vs. FactSet Est of $-0.60 - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Recall Affecting Diabetic Patients in 29 States Receives FDA’s Highest Risk Warning - The Healthy @Reader's Digest
Insights into Tandem Diabetes Care's Upcoming Earnings - Nasdaq
Tandem Diabetes (TNDM) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Automated Insulin Delivery System Market Is Booming Worldwide - openPR.com
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab - Yahoo Finance
When the Price of (TNDM) Talks, People Listen - news.stocktradersdaily.com
Reasons to Hold TNDM Stock in Your Portfolio for Now - MSN
RBC Capital Adjusts Tandem Diabetes (TNDM) Price Target Before Q - GuruFocus
RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating - marketscreener.com
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks - Yahoo Finance
Mizuho Initiates Coverage of Tandem Diabetes Care (LSE:0M0F) with Neutral Recommendation - Nasdaq
Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last? - Yahoo Finance
Mizuho Initiates Coverage of Tandem Diabetes Care (TNDM) with Neutral Recommendation - Nasdaq
Forecasting The Future: 9 Analyst Projections For Tandem Diabetes Care - Benzinga
11.62%
0.20%
자본화:
|
볼륨(24시간):